{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:41:44Z","timestamp":1781008904154,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejca.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T22:07:11Z","timestamp":1614982031000},"page":"161-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy"],"prefix":"10.1016","volume":"147","author":[{"given":"Aliz\u00e9","family":"Pacaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-5251","authenticated-orcid":false,"given":"Samuel","family":"Amintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Boussemart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cappellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.02.001_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and Trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.02.001_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.02.001_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2019.08.029","article-title":"BRAF exon 11 mutant melanoma and sensitivity to BRAF\/MEK inhibition: two case reports","volume":"121","author":"Melin","year":"2019","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.02.001_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2021.02.001_bib5","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/S0959-8049(16)33022-2","article-title":"Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib","volume":"69","author":"Mehnert","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.02.001_bib6","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1158\/0008-5472.CAN-16-2479","article-title":"High-throughput genomic profiling of adult solid tumors reveals novel insights into cancer pathogenesis","volume":"77","author":"Hartmaier","year":"2017","journal-title":"Canc Res"},{"key":"10.1016\/j.ejca.2021.02.001_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cancergen.2016.09.002","article-title":"A new NFIA:RAF1 fusion activating the MAPK\u00a0pathway in pilocytic astrocytoma","volume":"209","author":"Yde","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.ejca.2021.02.001_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejca.2021.02.001_bib9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1172\/JCI123089","article-title":"Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion","volume":"129","author":"McEvoy","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2021.02.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00138","article-title":"Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion","author":"Kim","year":"2018","journal-title":"JCO Precis. Oncol."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:12Z","timestamp":1760733072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":10,"alternative-id":["S0959804921000502"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.02.001","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}